The Apex Court on Tuesday allowed a Mumbai woman to abort her 24-week-old foetus as an exception under the Medical Termination of Pregnancy (MTP) Act, 1971.
The judgment came after Mumbai's KEM Hospital medical board report stated that 24-week-old foetus had no kidneys and would most likely die after birth. The hospital board further said in its reports that continuation of pregnancy would endanger mother's life.
The woman approached the court, while she was in her 21st week of pregnancy, after the foetal growth irregularity termed as bilateral renal agenesis was diagnosed. This means absence or failure of both kidneys in body.
Earlier, a 22-year-old Thane woman was allowed to undergo abortion after the Supreme Court observed that the foetus suffered from anencephaly, a life threatening condition in which the skull is not fully developed.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
